MATINAS BIOPHARMA HOLDINGS, INC. Restricted Cash and Cash Equivalents
MATINAS BIOPHARMA HOLDINGS, INC. (MTNB) had Restricted Cash and Cash Equivalents of $250.00 thousand as of 2023-03-31, per its 10-Q filed 2023-05-10.
Discontinued › Balance Sheet › Assets
us-gaap:RestrictedCashAndCashEquivalents · last filed 2023-05-10
- 2023-03-31: Restricted Cash and Cash Equivalents $250.00K.
- 2022-12-31: Restricted Cash and Cash Equivalents $250.00K.
- 2022-09-30: Restricted Cash and Cash Equivalents $250.00K.
- 2022-06-30: Restricted Cash and Cash Equivalents $250.00K.
| Period end | Restricted Cash and Cash Equivalents | Restricted Cash and Cash Equivalents as first filed |
|---|---|---|
| 2023-03-31 | $250.00K 10-Q · filed 2023-05-10 | |
| 2022-12-31 | $250.00K 10-Q · filed 2023-05-10 | |
| 2022-09-30 | $250.00K 10-Q · filed 2022-11-02 | |
| 2022-06-30 | $250.00K 10-Q · filed 2022-08-11 | |
| 2022-03-31 | $250.00K 10-Q · filed 2023-05-10 | |
| 2021-12-31 | $250.00K 10-Q · filed 2023-05-10 | |
| 2021-09-30 | $250.00K 10-Q · filed 2022-11-02 | |
| 2021-06-30 | $336.00K 10-Q · filed 2022-08-11 | |
| 2021-03-31 | $336.00K 10-Q · filed 2022-05-12 | |
| 2020-12-31 | $336.00K 10-K · filed 2023-03-15 | |
| 2020-09-30 | $386.00K 10-Q · filed 2021-11-08 | $386.00 10-Q · filed 2020-11-06 |
| 2020-06-30 | $486.00K 10-Q · filed 2021-08-10 | $486.00 10-Q · filed 2020-08-10 |
| 2020-03-31 | $486.00K 10-Q · filed 2021-05-10 | $486.00 10-Q · filed 2020-05-11 |
| 2019-12-31 | $586.00K 10-K/A · filed 2022-03-11 | $586.00 10-Q · filed 2020-05-11 |
| 2019-09-30 | $586.00 10-Q · filed 2020-11-06 | |
| 2019-06-30 | $586.00 10-Q · filed 2020-08-10 | |
| 2018-12-31 | $561.00K 10-K · filed 2021-03-29 | $561.00 10-Q · filed 2020-08-10 |
| 2017-06-30 | $155.38K 10-Q · filed 2017-08-08 | |
| 2017-03-31 | $155.64K 10-Q · filed 2017-05-15 | |
| 2016-12-31 | $155.61K 10-Q · filed 2017-08-08 | |
| 2016-09-30 | $55.58K 10-Q · filed 2016-11-14 | |
| 2016-06-30 | $55.56K 10-Q · filed 2016-08-15 | |
| 2016-03-31 | $100.38K 10-Q · filed 2016-05-13 | |
| 2015-12-31 | $100.33K 10-K · filed 2017-03-31 | |
| 2015-09-30 | $100.00K 10-Q · filed 2015-11-10 | |
| 2015-06-30 | $100.00K 10-Q · filed 2015-08-13 | |
| 2015-03-31 | $100.00K 10-Q · filed 2015-05-15 | |
| 2014-12-31 | $100.00K 10-K · filed 2016-03-30 | |
| 2013-12-31 | $0.00 10-K · filed 2015-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| Nexentis Technologies Inc. (NXTS) | $0.002B |